Dr Marie-Thérèse Dejardin SRL
Dr Marie-Thérèse Dejardin reported total assets of 417,318 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jun 2026).
By total assets for 2025, Dr Marie-Thérèse Dejardin ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr Marie-Thérèse Dejardin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +20 % Total assets +30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr Marie-Thérèse Dejardin's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 39,303 € | ||||
| Equity | 366,851 € | ||||
| Cash | 85,498 € | ||||
| EBITDA | 113,786 € | ||||
| Total assets | 417,318 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 15 Jun 2026
- Year ended 30 Sep 2024filed on 27 Mar 2025
- Year ended 30 Sep 2023filed on 27 Mar 2024
- Year ended 30 Sep 2022filed on 23 Mar 2023
- Year ended 30 Sep 2021filed on 28 Mar 2022
Dr Marie-Thérèse Dejardin's financial analysis
- Solvency87.9%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr Marie-Thérèse Dejardin
Dr Marie-Thérèse Dejardin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0899.002.829
- VAT number
- BE0899002829
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 03 Jul 2008
- Registered office
- 4000 Liège
- Latest accounts
- 2025 · filed on 15 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr Marie-Thérèse Dejardin (SRL) has been based in Liège since 2008, active in: medical specialists activities. For 2025, it reports a net profit of 39,303 € and equity of 366,851 €; its revenue is not published. Its solvency stands at 87.9%, above the median of its sector (65.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr Marie-Thérèse Dejardin
Companies in the same business, of comparable size and area, outside its group.
Frequently asked questions about Dr Marie-Thérèse Dejardin
What is the revenue of Dr Marie-Thérèse Dejardin?
Dr Marie-Thérèse Dejardin files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr Marie-Thérèse Dejardin?
In Belgium, the VAT number is the company number prefixed with BE: BE0899002829 for Dr Marie-Thérèse Dejardin, if the company is VAT-registered. Its company number (CBE) is 0899.002.829.
Where is the registered office of Dr Marie-Thérèse Dejardin?
According to the CBE register, the registered office of Dr Marie-Thérèse Dejardin is in 4000 Liège.
What is the equity of Dr Marie-Thérèse Dejardin?
At the close of the 2025 financial year, the equity of Dr Marie-Thérèse Dejardin amounts to 366,851 €, a solvency of 87.9% of total assets.
Who manages Dr Marie-Thérèse Dejardin?
The register lists 1 active mandates at Dr Marie-Thérèse Dejardin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr Marie-Thérèse Dejardin within its sector?
By total assets for 2025, Dr Marie-Thérèse Dejardin ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Dr Marie-Thérèse Dejardin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →